The REDOXS © Study REducing Deaths from OXidative Stress PART 4 of 4 Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.

Slides:



Advertisements
Similar presentations
Clinical research and the electronic medical record: Interdisciplinary research agendas Michael G. Kahn MD, PhD Biomedical Informatics Core Director Colorado.
Advertisements

SEPSIS KILLS program Adult Inpatients
The Impact of Enteral Feeding Protocols on Enteral Nutrition Delivery: Results of a multicenter observational study Rupinder Dhaliwal, RD Daren K. Heyland,
The REDOXS © Study REducing Deaths from OXidative Stress Dietitian and Pharmacy Training March 2009 Study Chair Dr. Daren Heyland, MD, FRCPC Project Leaders.
Understanding Maternal Death Reviews MDR Workshop Lucknow India June 17-18, 2010.
The REDOXS © Study REducing Deaths from OXidative Stress Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.
The REDOXS © Study REducing Deaths from OXidative Stress Study Chair Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.
Case Report Form Start-up Meeting March 25, 2010 Kingston, ON.
The REDOXS © Study REducing Deaths from OXidative Stress March 2009 Study Chair Dr. Daren Heyland, MD, FRCPC Project Leaders Rupinder Dhaliwal, RD and.
Physician Admission and Discharge Medication Reconciliation Training Guide June
QUESTIONS AND ANSWERS. A patient is admitted to the surveillance specialty with a catheter in situ Are they included in CAUTI surveillance?
The Redesigned National Hospital Discharge Survey National Center for Health Statistics Division of Health Care Statistics Hospital Care Team Last Updated:
Physician Multidisciplinary Discharge Routine Training Guide June 2015.
SEPSIS Early recognition and management. Aims of the talk Understand the definition of sepsis and severe sepsis Understand the clinical significance of.
NOSOCOMIAL INFECTION SURVEILLANCE METHODS Masud Yunesian, M.D., Epidemiologist.
INCLUSION/EXCLUSION CRITERIA 1. The following are considerations when defining the cardiac arrest trial patient population (i.e., the inclusion/exclusion.
E-DISCHARGE MEDICATION MODULE Last updated: 2/9/151.
SAE Report CTT21 V To:Quality Assurance Research & Development 34 Hyde Terrace LS2 9LN Date:…………………………….. Fax To:+44(0) From (name):………………………..
The Cardiac Surgery Translational Study (“CSTS”) The Quality And Safety Research Group Data We Can Count On Lisa H. Lubomski, PhD April 8, 2011 Immersion.
Consent Training Module Version 4: August 7th, 2013.
Joint Research & Enterprise Office Training The team, the procedures, the monitor and the Sponsor Lucy H H Parker Clinical Research Governance Manager.
Collecting data in clinic.  Aim of BADBIR  Definition of Adverse Events  Adverse events in BADBIR  Adverse event recording in hospital case notes.
A RandomizEd Trial of ENtERal Glutamine to MinimIZE Thermal Injury Study Sponsors Dr. Paul Wischmeyer (US) Dr. Dominique Garrel (Canada) Clinical Evaluation.
Architecture Design of Generic Outcome Adjudication in CTMS Wenle Zhao, PhD Medical University of South Carolina, Charleston, SC, 29425, USA Society for.
Components of HIV/AIDS Case Surveillance: Case Report Forms and Sources.
Study Procedures & Operational Issues Start-up Meeting March 25, 2010 Kingston, ON.
AE/SAE/EAE Identification and Reporting AE/SAE/EAE Identification and Reporting.
Mortality review Brian Bjørn, M.D. International Forum on Quality Improvement in Health Care Paris – April 9, 2014 Danish Society for Patient Safety.
Heart Failure Palliative Care/Heart Failure Audit.
The REDOXS © Study REducing Deaths from OXidative Stress Part 3 of 3 Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD.
Query Module Self-Training Module (v. 23-Apr-2013) International Nutrition Survey 2013.
International Critical Care Nutrition Survey 2009: Defining Gaps in Practice Naomi E Cahill, RD MSc Project Leader Queen’s University and Clinical Evaluation.
EAE Training EAE Reporting and Assessment Overview DAIDS Regional Training Event, Regulatory Compliance Center Kampala, Uganda, September 2009 DAIDS Regional.
Infection Adjudication on REDCAP Module 1 Version: Feb 1st, 2012.
Quality Education for a Healthier Scotland Pharmacy Pharmaceutical Care Planning Vocational Training Scheme: Level = Stage 2 Arlene Shaw Specialist Clinical.
The REDOXS© Study REducing Deaths from OXidative Stress PART 1 of 4
Mette Krag, MD, coordinating investigator
REDOXS Training: Introduction & Site Investigator
+ What to Do When Early Enteral Feeding is Not Possible in Critically Ill Patients? Results of a Multicenter Observational Study Naomi E Cahill RD MSc.
Stress Ulcer Prophylaxis in the Intensive Care Unit (SUP-ICU) SAR/SUSAR Mette Krag Dept. of Intensive Care 4131 Copenhagen University Hospital Rigshospitalet,
Supplementary Prescribing in a neonatal ICU
Role of Site Investigator Ensure subject safety is protected & well-managed Full compliance with requirements of Good Clinical Practice (GCP) Conduct the.
A RandomizEd Trial of ENtERal Glutamine to MinimIZE Thermal Injury: A multicenter Pragmatic RCT (definitive study) Study Sponsor Dr. Daren Heyland Clinical.
Quality Improvement and Performance Indicators Prepared by : Samah Darwazeh Thalassemia Center.
D3 ) Not Recovered d5) Fatal Was a post-mortem undertaken?YesNo Was the SAE ongoing at time of death from other cause? Yes No d d m m y y y y d1) Recovered.
The Department of Quality and Risk Management
REPORTING ADVERSE EVENTS AND COMPLETING THE REPORT FORM
Søren Marker Jensen, MD, coordinating investigator
REducing Deaths due to OXidative Stress
Safety Reporting Nichol McBee, MPH, CCRP.
The REDOXS© Study REducing Deaths from OXidative Stress Part 1 of 3
Copenhagen University Hospital Rigshospitalet, Denmark
*Continue on SAE supplemental page CTT21 A if more space is required
Supplementary Prescribing in a neonatal ICU
9. Introduction to signal detection
The Cardiovascular Inflammation Reduction Trial (CIRT)
REducing Deaths due to OXidative Stress: The REDOXS© Study: Can we provide adequate enteral nutrition to patients with Shock? Rupinder Dhaliwal John.
Home First.
Hospitalization in double-occupancy rooms and the risk of hospital-acquired influenza: a prospective cohort study  E. Munier-Marion, T. Bénet, C. Régis,
Nibble The Importance of Nutritional Adequacy
Hospital Antibiotic Stewardship Programs
The REDOXS© Study REducing Deaths from OXidative Stress Part 2 of 3
Consent Training Module
Improvement Targets High Performance
Copenhagen University Hospital Rigshospitalet, Denmark
The REDOXS© Study REducing Deaths from OXidative Stress
Queries Training Module.
The REDOXS© Study REducing Deaths from OXidative Stress PART 2 of 4
Cessation of screening for intestinal carriage of extended-spectrum β-lactamase- producing Enterobacteriaceae in a low-endemicity intensive care unit with.
The REDOXS© Study REducing Deaths from OXidative Stress PART 3 of 4
Presentation transcript:

The REDOXS © Study REducing Deaths from OXidative Stress PART 4 of 4 Sponsor Dr. Daren Heyland, MD, FRCPC Project Leader Rupinder Dhaliwal, BASc, RD

Site Investigator

Delegation of Authority Refer to Site Investigator Training Package Eligibility of patients Refer to inclusion/exclusion cards

ICU Infection Adjudication

Infection Adjudication All input warnings must be resolved Imp Manual: p 52

Microbiology Collect all positive cultures within the period 7 days prior to ICU admission. If culture date> 72 hrs ICU admission, 2 questions will be asked to help determine suspicion of ICU acquired infection. Imp Manual: p 42

Suspicion of ICU Infection Is this culture a manifestation of a previously diagnosed infection? Is this a routine surveillance swab? NEED TO ASK SITE INVESTIGATOR If NO to both………………..flag for adjudication (to be done after ICU outcomes).

Imp Manual: p 42

Antibiotics Period of data collection starts 7 days prior to ICU admission and may extend beyond ICU discharge. If abx started > 72 hr ICU admission, 2 questions will be asked to help determine suspicion of ICU acquired infection. Imp Manual: p 45

Suspicion of ICU Infection Is this antibiotic prescribed for prophylaxis? Is this a substitute for an antibiotic ordered for a previous infection? NEED TO ASK SITE INVESTIGATOR If NO to ALL………………..flag for adjudication (to be done after ICU outcomes).

Imp Manual p 45

Automatic listing of relevant clinical data (microbiology. antibiotics, daily data) that will enable the Site Investigator to adjudicate newly acquired ICU infections. Imp Manual: p 53

No Possible** NO END Was this culture or the prescription of this antibiotic for a NEW ICU acquired infection? (after 72 hours of admission from ICU admission)? Choose the appropriate Categories of Infection (1-12)* and if: Definite Yes or Probable Yes or Possible Yes Yes NO, because it is related to an infection previously diagnosed and adjudicated. NO, because it is NOT an infection END Probable* * NO Determination of ICU Infection *Categories of Infection: Appendix 8.2 **Definition of No: Appendix 8.3 Imp Manual: p 52-55

SAE Reporting Serious and Unexpected events –regardless of relationships to supplements Initial report faxed within 48 hrs Final report at day 30, ICU d/c, death or 10 days from becoming aware of SAE Record the event, not the outcome (death) Imp Manual: SAE

SAE Initial Report Cardiac arrest

SAE Follow up Report DM II, COPD, Hiatus Hernia CABG x 3 July 27 th 2007, IABP, pressor support, cardiac arrest, resuscitation OR 27/07/07, enrolled 28/07/07, cardiac arrest, pacer wires non functioning, no cardiac output Pt was improving overall. Less inotropic support needed. Onset of asystole/cardiac arrest was unexpected No relationship Patient suffered terminal cardiac arrest following salvage cardiac bypass grafting

Investigator’s Confirmation Only appears once the ICU and Hospital outcomes have been completed and all input warnings have been resolved (Patient Status Page). Do you want to finalize patient ? Yes…only if sure that no more changes Imp Manual: p 61

What to do ? Volume of enteral study supplements received was 300 mls due to high GRVs. Volume of parenteral study supplements received was 480 mls. Antibiotic: Ceftazidime after 72 hrs ICU admission but I cannot tell if this is due to prophylaxis. SAE: died as a result of a ventricular tachycardia…do I report this as a SAE or not?